SURF Earnings & Forecasts - Benzinga

SPY769.24−0.05%QQQ749.02−0.07%BTC/USD84,560.00−0.34%DIA511.11+0.00%GLD380.90+0.20%TLT77.54+0.08%

SURF

SURFNasdaq Private Market

Private market price is not available

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

SURF Earnings & Forecasts - Benzinga

SURF Earnings & Forecasts

SURF (SURF) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

SURF Guidance

Recent Earnings Results

Metric	Q2 '23	Q1 '23	Q4 '22	Q3 '22
Earnings Per Share (Non-GAAP)
Estimate	$-0.34	$-0.36	$-0.33	$-0.47
Actual	$-0.46	$-0.33	$-0.35	$-0.39
Surprise	-35.3%	+8.33%	-6.06%	+17.0%
Revenue
Estimate	—	—	$2.5M	$80000
Actual	$0	$0	$0	$0
Surprise	—	—	-100.0%	-100.0%

Earnings & Guidance News

PRO
Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate

Surface Oncology (NASDAQ:SURF) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.34) by 35.29 percent. This is unchanged from the same period last year.

Benzinga Newsdesk

Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June

U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P 500, also fell, dropping, 0.29% to 4,412.88.

Lisa Levin

Crude Oil Rises; Adobe Posts Upbeat Results

U.S. stocks traded slightly higher midway through trading, with Dow Jones gaining around 20 points on Friday. The Dow traded up 0.06% to 34,428.13 while the NASDAQ rose 0.05% to 13,789.23. The S&P 500, also rose, gaining, 0.19% to 4,434.03.

Lisa Levin

US Stocks Mixed; Dow Gains 50 Points

U.S. stocks traded mixed this morning, with Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.16% to 34,464.01 while the NASDAQ fell 0.14% to 13,763.40. The S&P 500, also rose, gaining, 0.10% to 4,430.43.

Lisa Levin

Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M

Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that

Vandana Singh

Recap: Surface Oncology Q1 Earnings

Benzinga Insights

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q2	Aug 2, 2023	$-0.46	$-0.34	-35.3 %
Q1	May 4, 2023	$-0.33	$-0.36	8.33 %
Q4	Mar 9, 2023	$-0.35	$-0.33	-6.06 %
Q3	Nov 2, 2022	$-0.39	$-0.47	17.0 %

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q4	Mar 9, 2023	$0	$2.50M	-100.0 %
Q3	Nov 2, 2022	$0	$80.00K	-100.0 %
Q2	Aug 3, 2022	$0	$100.00K	-100.0 %
Q1	May 9, 2022	$30.00M	$10.48M	186.3 %